Consensus on Diagnosis and Empiric Antibiotic Therapy of Febrile Neutropenia
1
Department of Pediatrics, IRCCS Burlo Garofolo, Trieste, Italy
2
Department of Oncohematology, IRCCS Burlo Garofolo, Trieste, Italy
*
Author to whom correspondence should be addressed.
Pediatr. Rep. 2011, 3(1), e4; https://doi.org/10.4081/pr.2011.e4
Submission received: 16 November 2010
/
Accepted: 14 December 2010
/
Published: 24 February 2011
Abstract
Controversial issues on the management of empiric therapy and diagnosis of febrile neutropenia (FN) were faced by a Consensus Group of the Italian Association of Pediatric Hematology-Oncology (AIEOP). In this paper we report the suggestions of the consensus process regarding the role of aminoglycosides, glycopeptides and oral antibiotics in empiric therapy of FN, the rules for changing or discontinuing the therapy as well as the timing of the blood cultures.
Keywords:
neutropenia; antibiotic therapy
Share and Cite
MDPI and ACS Style
Giurici, N.; Zanazzo, G.A. Consensus on Diagnosis and Empiric Antibiotic Therapy of Febrile Neutropenia. Pediatr. Rep. 2011, 3, e4. https://doi.org/10.4081/pr.2011.e4
AMA Style
Giurici N, Zanazzo GA. Consensus on Diagnosis and Empiric Antibiotic Therapy of Febrile Neutropenia. Pediatric Reports. 2011; 3(1):e4. https://doi.org/10.4081/pr.2011.e4
Chicago/Turabian StyleGiurici, Nagua, and Giulio A. Zanazzo. 2011. "Consensus on Diagnosis and Empiric Antibiotic Therapy of Febrile Neutropenia" Pediatric Reports 3, no. 1: e4. https://doi.org/10.4081/pr.2011.e4
